About
Vascular access device for hemodialysis patients
Areas of Focus
Categories
Medical ImplantMidwest
Team (7)
Alex Yevzlin
Chief Executive Officer
Phraxis
executive
Geoff Beecher BSc
Chief Commercial Officer
Phraxis
team_member
John R
Lead Principal Investigator
Phraxis
team_member
John Rappe
Board Member
Phraxis
team_member
John Zentgraf
Chief Operating Officer
Phraxis
executive
Leota Pearson
Chief Financial Officer
Phraxis
executive
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
320
By Phase
NA: 2
By Status
COMPLETED: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07146854Lead Sponsor
EndoForce Post Approval Study
N/ANot yet recruiting
150 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2029
NCT05448950Lead Sponsor
Continued Access Study VIG Anastomotic Connector
NACompleted
12 participants
Started: Jun 7, 2022 · Completed: Mar 8, 2023
NCT02532621Lead Sponsor
Clinical Evaluation of a Vascular Venous Anastomotic Connector [InterGraft VIG-only Study]
NACompleted
158 participants
Started: Feb 21, 2018 · Completed: Jan 19, 2022
Locations (1)
Headquarters
St. Paul, MN, United States
Map
Loading map...